$SRPT Sarepta Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sarepta Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Sarepta Therapeutics, Inc. for free.
IRS Number: 930797222
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SRPT
Company Address: 215 FIRST STREET SUITE 415 CAMBRIDGE 02142
Phone number: 617-274-4000
Former name: ANTIVIRALS INC, date of change: 1997-01-23
Former name: Sarepta Therapuetics, Inc., date of change: 2012-07-12
Former name: AVI BIOPHARMA INC, date of change: 1998-09-30
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Market Capitalization: $1.60B
Prev close: $29.17
Average Daily Volume: 2,488,980
Days Low: $28.68
Year Low: $8.00
Year High: $63.73
Sarepta Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | M | 42.30 | 5,000 | 211,500 | 0 | |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Sell | S | 85.76 | 5,000 | 428,800 | 130,517 | 135.5 K to 130.5 K (-3.69 %) |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | M | 42.30 | 5,000 | 211,500 | 135,517 | 130.5 K to 135.5 K (+3.83 %) |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 34.92 | 10,000 | 349,200 | 0 | |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 83.51 | 10,000 | 835,100 | 16,518 | 26.5 K to 16.5 K (-37.71 %) |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 34.92 | 10,000 | 349,200 | 26,518 | 16.5 K to 26.5 K (+60.54 %) |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 2,726 | 0 | 16,518 | 13.8 K to 16.5 K (+19.77 %) |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Rodino-Klapac Louise | Chief Scientific Of ... | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Rodino-Klapac Louise | Chief Scientific Of ... | Grant | A | 0.00 | 15,000 | 0 | 22,169 | 7.2 K to 22.2 K (+209.23 %) |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 15,000 | 0 | 29,070 | 14.1 K to 29.1 K (+106.61 %) |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 2,726 | 0 | 11,852 | 9.1 K to 11.9 K (+29.87 %) |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 |